Similar articles

• An approach to neurometabolic disorders by a simple metabolic screen.

  Gulati S, Vaswani M, Kalra V, Kabra M, Kaur M. Gulati S, et al. Indian Pediatr. 2000 Jan;37(1):63-9. Indian Pediatr. 2000. PMID: 10745390 No abstract available.
• Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency.

  Schulze A, Hoffmann GF, Bachert P, Kirsch S, Salomons GS, Verhoeven NM, Mayatepek E. Schulze A, et al. Neurology. 2006 Aug 22;67(4):719-21. doi: 10.1212/01.wnl.0000230152.25203.01. Neurology. 2006. PMID: 16924036
• [Updating neonatal neurometabolic screening].

  Alfonso I, Charria G. Alfonso I, et al. Medicina (B Aires). 2009;69(1 Pt 1):36-40. Medicina (B Aires). 2009. PMID: 19240000 Review. Spanish.
• Neurometabolic diseases in the newborn.

  Filiano JJ. Filiano JJ. Clin Perinatol. 2006 Jun;33(2):411-79. doi: 10.1016/j.clp.2006.03.013. Clin Perinatol. 2006. PMID: 16765732 Review.
• Glutaric acidemia type I: a neurosurgical perspective. Report of two cases.

  Hou LC, Veeravagu A, Hsu AR, Enns GM, Huhn SL. Hou LC, et al. J Neurosurg. 2007 Aug;107(2 Suppl):167-72. doi: 10.3171/PED-07/08/167. J Neurosurg. 2007. PMID: 18459892